Lee P Richman, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoantigens | 1 | 2019 | 877 | 0.500 |
Why?
|
Receptors, CCR5 | 3 | 2021 | 487 | 0.400 |
Why?
|
Antigens, Neoplasm | 2 | 2019 | 1999 | 0.400 |
Why?
|
Immunotherapy | 4 | 2019 | 4637 | 0.330 |
Why?
|
Lymphocyte Transfusion | 2 | 2021 | 232 | 0.300 |
Why?
|
Computational Biology | 1 | 2019 | 3504 | 0.290 |
Why?
|
Graft vs Host Disease | 6 | 2021 | 3023 | 0.270 |
Why?
|
Software | 1 | 2019 | 4420 | 0.250 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2021 | 4554 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5248 | 0.180 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 9196 | 0.170 |
Why?
|
Ephrin-A2 | 1 | 2019 | 25 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2021 | 801 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2021 | 5644 | 0.160 |
Why?
|
Biomarkers, Pharmacological | 1 | 2019 | 162 | 0.160 |
Why?
|
Molecular Mimicry | 1 | 2019 | 200 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13249 | 0.160 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2021 | 825 | 0.150 |
Why?
|
Lymphocyte Subsets | 1 | 2018 | 310 | 0.140 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 600 | 0.140 |
Why?
|
Lymphocyte Activation | 3 | 2017 | 5498 | 0.130 |
Why?
|
Transplantation Conditioning | 3 | 2021 | 1593 | 0.130 |
Why?
|
Graft vs Tumor Effect | 1 | 2015 | 68 | 0.120 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 95 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 13629 | 0.110 |
Why?
|
HLA Antigens | 1 | 2019 | 1369 | 0.110 |
Why?
|
Toll-Like Receptor 9 | 1 | 2015 | 235 | 0.110 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2016 | 305 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1729 | 0.110 |
Why?
|
Donor Selection | 1 | 2015 | 228 | 0.110 |
Why?
|
Virus Replication | 1 | 2021 | 2431 | 0.110 |
Why?
|
alpha 1-Antitrypsin | 1 | 2013 | 169 | 0.110 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2013 | 113 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1090 | 0.100 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2014 | 280 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2021 | 1381 | 0.100 |
Why?
|
Antibody Specificity | 1 | 2014 | 1061 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 1956 | 0.100 |
Why?
|
Anti-Retroviral Agents | 1 | 2021 | 1780 | 0.090 |
Why?
|
B-Lymphocytes | 2 | 2015 | 4739 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5333 | 0.090 |
Why?
|
Receptors, IgG | 1 | 2014 | 565 | 0.090 |
Why?
|
Transgenes | 1 | 2013 | 1006 | 0.090 |
Why?
|
Imidazoles | 1 | 2016 | 1178 | 0.090 |
Why?
|
Proteome | 1 | 2019 | 1856 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10185 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1589 | 0.080 |
Why?
|
Dependovirus | 1 | 2013 | 708 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4355 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1811 | 0.070 |
Why?
|
Tumor Microenvironment | 2 | 2018 | 3826 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13456 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2019 | 14396 | 0.070 |
Why?
|
Interferon-gamma | 1 | 2015 | 3160 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2016 | 2093 | 0.060 |
Why?
|
Transplantation, Homologous | 3 | 2021 | 4814 | 0.060 |
Why?
|
Neoplasms | 1 | 2014 | 22066 | 0.060 |
Why?
|
Adenocarcinoma | 2 | 2019 | 6310 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2013 | 3378 | 0.060 |
Why?
|
HIV-1 | 1 | 2021 | 6850 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2015 | 1899 | 0.050 |
Why?
|
Mice | 7 | 2021 | 81216 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10183 | 0.050 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2021 | 17 | 0.050 |
Why?
|
Protein Binding | 1 | 2014 | 9336 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3076 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 11902 | 0.040 |
Why?
|
Receptor, EphA2 | 1 | 2019 | 41 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2021 | 825 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29636 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18134 | 0.040 |
Why?
|
Animals | 7 | 2021 | 167940 | 0.040 |
Why?
|
Sulfoxides | 1 | 2016 | 46 | 0.030 |
Why?
|
Anemia, Refractory, with Excess of Blasts | 1 | 2016 | 16 | 0.030 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2016 | 85 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2017 | 183 | 0.030 |
Why?
|
B-Cell Activating Factor | 1 | 2016 | 115 | 0.030 |
Why?
|
Melanoma | 1 | 2014 | 5695 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2016 | 366 | 0.030 |
Why?
|
Humans | 13 | 2021 | 760261 | 0.030 |
Why?
|
Blood Preservation | 1 | 2016 | 168 | 0.030 |
Why?
|
Receptors, CCR2 | 1 | 2016 | 215 | 0.030 |
Why?
|
Radiation Chimera | 1 | 2015 | 216 | 0.030 |
Why?
|
Histocompatibility | 1 | 2016 | 316 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5797 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1354 | 0.030 |
Why?
|
Myeloablative Agonists | 1 | 2015 | 209 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17159 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22025 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2015 | 5873 | 0.030 |
Why?
|
Lymphopoiesis | 1 | 2015 | 133 | 0.030 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2013 | 94 | 0.030 |
Why?
|
Antigens, Ly | 1 | 2015 | 293 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2016 | 877 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 591 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2015 | 468 | 0.030 |
Why?
|
Chemotaxis | 1 | 2016 | 598 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3584 | 0.030 |
Why?
|
Epigenomics | 1 | 2018 | 936 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2013 | 553 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3323 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2668 | 0.020 |
Why?
|
Capsid | 1 | 2013 | 434 | 0.020 |
Why?
|
Male | 9 | 2021 | 359413 | 0.020 |
Why?
|
Middle Aged | 7 | 2021 | 220175 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1558 | 0.020 |
Why?
|
Cryopreservation | 1 | 2016 | 720 | 0.020 |
Why?
|
CpG Islands | 1 | 2015 | 1221 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6900 | 0.020 |
Why?
|
Clone Cells | 1 | 2013 | 1663 | 0.020 |
Why?
|
Female | 9 | 2021 | 391011 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3613 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4358 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2042 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1720 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2394 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3810 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2918 | 0.020 |
Why?
|
Inflammation | 2 | 2019 | 10757 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6830 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2574 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2414 | 0.020 |
Why?
|
Graft Survival | 1 | 2016 | 3793 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5201 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2015 | 1933 | 0.020 |
Why?
|
Trans-Activators | 1 | 2015 | 2861 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8157 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2017 | 64947 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15626 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3735 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16905 | 0.010 |
Why?
|
Aged | 4 | 2018 | 168995 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12806 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3770 | 0.010 |
Why?
|
Adult | 4 | 2021 | 219847 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8487 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3390 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9388 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6775 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5745 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7345 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7593 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18968 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3606 | 0.010 |
Why?
|
Rats | 1 | 2016 | 23695 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7854 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4923 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11480 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29950 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2016 | 26168 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58947 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23363 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 58673 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 74269 | 0.000 |
Why?
|
Adolescent | 1 | 2015 | 87747 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2015 | 80301 | 0.000 |
Why?
|